🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07657962
Recruiting Observational

Autologous Free Dermal Graft Support in Superior Pedicle Vertical Scar Reduction Mammaplasty

NCT07657962 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-08-24
Last updated
2026-08-25

Condition(s) studied

Breast PtosisMammaplastyLower Pole ElongationPostoperative Breast Pseudoptosis

Investigational drug(s) / intervention(s)

Autologous Free Dermal Graft Support

Autologous Free Dermal Graft Support: Placement of a de-epithelialized autologous free dermal graft in the lower pole region during superior pedicle vertical scar reduction mammaplasty. The dermal graft is obtained from the participant's own de-epithelialized skin during the planned breast reduction procedure and is used as an autologous structural support method. The graft is not vascularized and does not remain attached to a dermal or glandular pedicle. No synthetic or biological mesh material is used.

Study summary

The goal of this observational study is to learn whether using an autologous free dermal graft during breast reduction surgery helps maintain lower breast pole shape over time in women undergoing primary bilateral reduction mammaplasty.

The main question it aims to answer is:

Does autologous free dermal graft support reduce lower pole lengthening between 1 month and 6 months after surgery?

Researchers will compare two groups of participants. One group will undergo superior pedicle vertical scar reduction mammaplasty with autologous free dermal graft support as part of routine surgical care. The other group will undergo the same basic breast reduction technique without autologous free dermal graft support.

Participants will:

* Have their planned breast reduction surgery as part of routine care
* Attend postoperative follow-up visits at 1, 3, and 6 months
* Have standard breast measurements and medical photographs taken during follow-up
* Complete a breast satisfaction questionnaire at 6 months

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Female participants aged 18 to 65 years * Planned primary bilateral reduction mammaplasty * Planned use of the superior pedicle vertical scar technique * Willingness to attend at least 6 months of postoperative follow-up * Ability to provide written informed consent * Consent for standardized medical photography and clinical breast measurements Exclusion Criteria: * Previous breast surgery * Oncoplastic breast reduction * Unilateral reduction mammaplasty * Use of a pedicle technique other than the superior pedicle * Use of a scar pattern other than the vertical scar pattern * Presence of a systemic condition expected to significantly impair wound healing * Active smoking within the last 6 weeks before surgery * Incomplete 6-month follow-up data for the primary outcome analysis

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sivas Cumhuriyet University Sivas Sivas Recruiting

More Cumhuriyet University Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07657962 on ClinicalTrials.gov ↗ ← All trials in Turkey